aminosalicylates in ibd: new data on an old therapy
Published 9 years ago • 1K plays • Length 13:54Download video MP4
Download video MP3
Similar videos
-
21:36
keynote: evolution of disease management in ibd
-
21:01
transitional care in ibd: who is it for, and how should we do this?
-
28:54
treat to target in ibd
-
18:23
selection and use of the new and coming therapies for ibd? who? when? how?
-
21:30
ibd: beyond combination therapy
-
12:58
positioning of biologics and new therapeutics for crohn's disease
-
27:12
evaluating and treating pain in ibd
-
29:46
case discussion: when and how to modify ibd therapies
-
12:48
ibd clinical update: new and emerging targeted therapies
-
12:04
pro: vedolizumab should be used before anti-tnfs for moderate to severe ibd
-
20:05
ibd pathogenesis: personalizing targets
-
16:27
dermatologic findings in ibd
-
24:47
diagnosis and management of infections in ibd patients on immunomodulators and biologics
-
16:13
when and how to use 5-asas, antibiotics, and steroids in ibd
-
21:25
first-line therapy options in ibd: understanding longitudinal severity
-
21:14
when and how to use immunomodulators and biologics in ibd
-
6:22
antibiotics and risk of new onset inflammatory bowel disease: a meta-analysis
-
23:51
beyond combination therapy in ibd: what have we learned?
-
18:38
ibd and extra intestinal manifestations: treatment options